Biomedical subjects
Publications and source records attributed to E I Helvig.
This article chronicles the development of an American Burn Association consensus document reflecting optimal goals for the delivery of burn care for use in clinical pathways and other quality improvement efforts. Outcome statements can measure progress toward meeting patient goals and can identify barriers in delivering optimal patient care.
Advances in the availability of products enhancing wound healing are changing current methods of burn care. Use of Integra artificial skin to provide a matrix for the development of a neodermis and other dermal replacement materials offer hope for more rapid wound healing and better functional and cosmetic results.
In a prospective, randomized study of 34 patients with thermal burns, treatment with the topical agent Cerium nitrate-silver sulfadiazine was compared with therapy with silver sulfadiazine alone. Despite randomization, there was a significant difference in mean burn size, being larger in the silver sulfadiazine group. There was no significant difference between the two groups in clinical course, mortality, septic deaths, or quantitative microbiology of the burn wound. It is concluded that from these preliminary data no clearcut superiority for one cream over the other can be demonstrated at this time.
Explore the source record for details and available documents.